39,650 Shares in CME Group Inc. $CME Purchased by Eurizon SLJ Capital Ltd

Eurizon SLJ Capital Ltd bought a new stake in CME Group Inc. (NASDAQ:CME) during the 4th quarter, Holdings Channel reports. The firm bought 39,650 shares of the financial services provider’s stock, valued at approximately $10,828,000. CME Group accounts for about 4.3% of Eurizon SLJ Capital Ltd’s portfolio, making the stock its 7th largest holding.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Eurizon Capital SGR S.p.A. acquired a new position in CME Group in the 4th quarter valued at about $15,732,000. Fideuram Asset Management Ireland dac acquired a new position in CME Group in the 4th quarter valued at about $1,718,000. FUKOKU MUTUAL LIFE INSURANCE Co boosted its holdings in CME Group by 2,935.8% in the 4th quarter. FUKOKU MUTUAL LIFE INSURANCE Co now owns 46,327 shares of the financial services provider’s stock valued at $12,651,000 after purchasing an additional 44,801 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in CME Group in the 4th quarter valued at about $230,000. Finally, Linscomb Wealth Inc. boosted its holdings in CME Group by 6.5% in the 4th quarter. Linscomb Wealth Inc. now owns 17,441 shares of the financial services provider’s stock valued at $4,763,000 after purchasing an additional 1,067 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 44,044 shares of company stock valued at $13,297,507. Company insiders own 0.30% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced that Chairman and CEO Terry Duffy will present at the Piper Sandler Global Exchange and Fintech Conference on June 4, which keeps the company visible to investors and may reinforce its growth story. Article Title
• Positive Sentiment: Recent coverage says CME’s planned 24/7 Bitcoin and Ethereum futures trading could attract more institutional crypto volume, which may support future derivatives activity and trading revenue. Article Title
• Neutral Sentiment: CME also lowered margin requirements on gold and silver futures, a move that may help keep trading active during volatile commodity markets but is not clearly a major fundamental catalyst. Article Title
• Neutral Sentiment: Macro commentary from the CME floor highlighted sticky inflation and stronger durable goods data, which could keep Fed policy uncertain and sustain trading activity, but the direct impact on CME stock is unclear. Article Title
• Negative Sentiment: Crypto articles suggesting Bitcoin’s “CME gap” may disappear with round-the-clock trading could reduce the market’s focus on CME-specific weekend price gaps, weakening one of the more visible trading narratives tied to the company’s crypto franchise. Article Title

Analysts Set New Price Targets

Several equities analysts have weighed in on CME shares. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Piper Sandler boosted their target price on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. Jefferies Financial Group decreased their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Finally, The Goldman Sachs Group decreased their target price on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a report on Thursday, April 23rd. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $305.29.

CME Group Price Performance

CME Group stock opened at $273.54 on Friday. The company’s 50 day simple moving average is $293.28 and its 200-day simple moving average is $289.51. The company has a market capitalization of $99.12 billion, a price-to-earnings ratio of 23.34, a price-to-earnings-growth ratio of 3.10 and a beta of 0.23. CME Group Inc. has a 1 year low of $257.17 and a 1 year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.80 EPS. As a group, equities research analysts expect that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.